• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液肿瘤学中未来患者发病率:一项利用日本癌症登记数据的研究。

Future Patient Incidence in Hemato-Oncology: A Study Using Data from Cancer Registries in Japan.

作者信息

Narimatsu Hiroto, Sakaguchi Masahiko, Nakamura Sho, Katayama Kayoko

机构信息

Cancer Prevention & Control Division, Kanagawa Cancer Center Research Institute, Yokohama 241-8515, Japan.

Graduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa 210-0821, Japan.

出版信息

Risk Manag Healthc Policy. 2020 Nov 3;13:2407-2414. doi: 10.2147/RMHP.S277207. eCollection 2020.

DOI:10.2147/RMHP.S277207
PMID:33173364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7648558/
Abstract

PURPOSE

The distribution of patients with hematological malignancies is expected to change markedly in the future due to aging of the Japanese population. We assessed the expected incidence rates of leukemia, malignant lymphoma, and multiple myeloma using national population estimates and data from the Kanagawa Cancer Registry.

PATIENTS AND METHODS

To evaluate the effects of community aging, we compared expected future incidences of hematological malignancies in Kanagawa with other three areas, namely the Yamagata, Osaka, and Nagasaki prefectures, which have different populations and predicted aging rates.

RESULTS

The total number of patients newly diagnosed with hematological malignancy in Kanagawa in 2010 was 1970. This was predicted to increase to 2581 by 2025 and to 2712 by 2040. Trends were very similar for all three hematological malignancies. These incidence rates were predicted to increase continuously in patients aged ≥65 years from 2010 to 2040, with a 169% increase in leukemia, a 167% increase in malignant lymphoma, and a 169% increase in multiple myeloma. A continuous increase in the population aged ≥65 years was also noted in the other three prefectures.

CONCLUSION

The distribution demographic of patients with hematological malignancies is expected to change in the future as the number of elderly patients increases.

摘要

目的

由于日本人口老龄化,预计未来血液系统恶性肿瘤患者的分布将发生显著变化。我们使用全国人口估计数和神奈川县癌症登记处的数据评估了白血病、恶性淋巴瘤和多发性骨髓瘤的预期发病率。

患者与方法

为评估社区老龄化的影响,我们将神奈川县血液系统恶性肿瘤的预期未来发病率与其他三个地区(即山形县、大阪府和长崎县)进行了比较,这三个地区的人口和预测老龄化率各不相同。

结果

2010年神奈川县新诊断为血液系统恶性肿瘤的患者总数为1970人。预计到2025年将增至2581人,到2040年将增至2712人。这三种血液系统恶性肿瘤的趋势非常相似。预计从2010年到2040年,年龄≥65岁患者的这些发病率将持续上升,白血病增加169%,恶性淋巴瘤增加167%,多发性骨髓瘤增加169%。其他三个县年龄≥65岁的人口也持续增加。

结论

随着老年患者数量的增加,预计未来血液系统恶性肿瘤患者的分布人口统计学将发生变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/a34c427f247c/RMHP-13-2407-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/744510456fb8/RMHP-13-2407-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/0da01bd3ef31/RMHP-13-2407-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/ab705ea71740/RMHP-13-2407-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/a34c427f247c/RMHP-13-2407-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/744510456fb8/RMHP-13-2407-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/0da01bd3ef31/RMHP-13-2407-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/ab705ea71740/RMHP-13-2407-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae42/7648558/a34c427f247c/RMHP-13-2407-g0004.jpg

相似文献

1
Future Patient Incidence in Hemato-Oncology: A Study Using Data from Cancer Registries in Japan.血液肿瘤学中未来患者发病率:一项利用日本癌症登记数据的研究。
Risk Manag Healthc Policy. 2020 Nov 3;13:2407-2414. doi: 10.2147/RMHP.S277207. eCollection 2020.
2
Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan.日本神奈川县老龄化社会中女性乳腺癌发病率的预测
PLoS One. 2016 Aug 17;11(8):e0159913. doi: 10.1371/journal.pone.0159913. eCollection 2016.
3
Trend analysis of cancer incidence in Japan using data from selected population-based cancer registries.日本癌症发病率的趋势分析,使用来自部分基于人群的癌症登记处的数据。
Cancer Sci. 2012 Feb;103(2):360-8. doi: 10.1111/j.1349-7006.2011.02145.x. Epub 2011 Dec 15.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
Regional social system for specialized medical care in hematologic malignancies: a pilot study.血液系统恶性肿瘤专科医疗的区域社会系统:一项试点研究。
Rural Remote Health. 2009 Jul-Sep;9(3):1106. Epub 2009 Jul 28.
6
Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan.HIV 感染者中的非艾滋病定义性血液系统恶性肿瘤:日本的一项流行病学研究。
AIDS. 2013 Jan 14;27(2):279-83. doi: 10.1097/QAD.0b013e32835a5a7a.
7
The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.原子弹幸存者中的白血病、淋巴瘤和多发性骨髓瘤的发病率:1950-2001 年。
Radiat Res. 2013 Mar;179(3):361-82. doi: 10.1667/RR2892.1. Epub 2013 Feb 11.
8
Trends in hematological cancer in the elderly in Denmark, 1980-2012.1980 - 2012年丹麦老年人血液系统癌症的发病趋势
Acta Oncol. 2016;55 Suppl 1:98-107. doi: 10.3109/0284186X.2015.1115124. Epub 2016 Jan 19.
9
Cancer incidence in France over the 1980-2012 period: Hematological malignancies.1980 - 2012年期间法国的癌症发病率:血液系统恶性肿瘤
Rev Epidemiol Sante Publique. 2016 Apr;64(2):103-12. doi: 10.1016/j.respe.2015.12.017. Epub 2016 Mar 10.
10
Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN).利用血液系统恶性肿瘤研究网络(HMRN)的数据估算血液系统恶性肿瘤及其前驱疾病的患病率。
Cancer Causes Control. 2016 Aug;27(8):1019-26. doi: 10.1007/s10552-016-0780-z. Epub 2016 Jun 28.

引用本文的文献

1
Association between socioeconomic background and cancer: An ecological study using cancer registry and various community socioeconomic status indicators in Kanagawa, Japan.社会经济背景与癌症之间的关联:一项使用日本神奈川县癌症登记数据及各类社区社会经济状况指标的生态学研究。
PLoS One. 2025 Jul 9;20(7):e0326895. doi: 10.1371/journal.pone.0326895. eCollection 2025.
2
Projection of future gastric cancer incidence and health-care service demand by geographic area in Kanagawa, Japan.日本神奈川县按地理区域对未来胃癌发病率及医疗服务需求的预测。
Cancer Sci. 2025 Feb;116(2):488-499. doi: 10.1111/cas.16415. Epub 2024 Nov 28.
3

本文引用的文献

1
National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens.泰国全国及地方基于人群的癌症发病率:评估负担最重的癌症。
Cancers (Basel). 2017 Aug 17;9(8):108. doi: 10.3390/cancers9080108.
2
Cancer incidence and mortality projections in the UK until 2035.英国到2035年的癌症发病率和死亡率预测。
Br J Cancer. 2016 Oct 25;115(9):1147-1155. doi: 10.1038/bjc.2016.304. Epub 2016 Oct 11.
3
Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan.
Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study.
日本癌症发病流行率预测及 2020-2050 年癌症负担变化的分解分析:一项统计建模研究。
Cancer Epidemiol Biomarkers Prev. 2023 Dec 1;32(12):1756-1770. doi: 10.1158/1055-9965.EPI-23-0754.
4
The ME-BYO index: A development and validation project of a novel comprehensive health index.ME-BYO 指数:一个新型综合健康指数的开发与验证项目。
Front Public Health. 2023 May 5;11:1142281. doi: 10.3389/fpubh.2023.1142281. eCollection 2023.
日本神奈川县老龄化社会中女性乳腺癌发病率的预测
PLoS One. 2016 Aug 17;11(8):e0159913. doi: 10.1371/journal.pone.0159913. eCollection 2016.
4
Anticipating the "Silver Tsunami": Prevalence Trajectories and Comorbidity Burden among Older Cancer Survivors in the United States.预测“银色海啸”:美国老年癌症幸存者的患病率轨迹与合并症负担
Cancer Epidemiol Biomarkers Prev. 2016 Jul;25(7):1029-36. doi: 10.1158/1055-9965.EPI-16-0133.
5
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030.美国肝细胞癌发病率至2030年的预测前景
J Clin Oncol. 2016 May 20;34(15):1787-94. doi: 10.1200/JCO.2015.64.7412. Epub 2016 Apr 4.
6
Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.预计 2030 年美国癌症发病与死亡人数:甲状腺癌、肝癌和胰腺癌带来的意外负担。
Cancer Res. 2014 Jun 1;74(11):2913-21. doi: 10.1158/0008-5472.CAN-14-0155.
7
Planning for the future: cancer incidence projections in Switzerland up to 2019.未来规划:瑞士 2019 年之前的癌症发病率预测。
BMC Public Health. 2014 Feb 1;14:102. doi: 10.1186/1471-2458-14-102.
8
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.欧洲癌症发病率和死亡率模式:2012 年 40 个国家的估计数。
Eur J Cancer. 2013 Apr;49(6):1374-403. doi: 10.1016/j.ejca.2012.12.027. Epub 2013 Feb 26.
9
Palliative care and hematologic oncology: the promise of collaboration.缓和医疗与血液肿瘤学:协作的前景。
Blood Rev. 2012 Nov;26(6):233-9. doi: 10.1016/j.blre.2012.07.001. Epub 2012 Aug 5.
10
Cancer incidence in the United Kingdom: projections to the year 2030.英国癌症发病率:预测至 2030 年。
Br J Cancer. 2011 Nov 22;105(11):1795-803. doi: 10.1038/bjc.2011.430. Epub 2011 Oct 27.